Lombard Odier Asset Management (Switzerland)’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-71,523
Closed -$1.22M 362
2022
Q3
$1.22M Sell
71,523
-50,356
-41% -$1.08M 0.1% 142
2022
Q2
$2.62M Buy
121,879
+63,327
+108% +$1.76M 0.22% 100
2022
Q1
$2.17M Buy
+58,552
New +$2.28M 0.17% 86

Other funds holding CDNA

Lombard Odier Asset Management (Switzerland)'s CDNA Position: Q4 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of CareDx (CDNA) in Q4 2022, closing a stake of 71,523 shares — an estimated $1.22M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in CDNA in Q1 2022 and held it in 3 quarters. The position peaked at $2.62M in Q2 2022. 168 funds tracked by Wall St. Rank hold CDNA as of Q4 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining CareDx position as of Q4 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 71,523 CareDx shares in Q4 2022, an estimated $1.22M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in CareDx in Q1 2022 and held it in 3 quarters.
  • Lombard Odier Asset Management (Switzerland)'s CareDx position peaked at $2.62M in Q2 2022.
  • 168 funds tracked by Wall St. Rank held CareDx as of Q4 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q4 2022, filed 14 Feb 2023.